These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12059947

  • 1. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.
    Stone SF, Price P, Keane NM, Murray RJ, French MA.
    HIV Med; 2002 Jan; 3(1):21-7. PubMed ID: 12059947
    [Abstract] [Full Text] [Related]

  • 2. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

  • 3. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.
    Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA.
    J Clin Virol; 2001 Oct; 22(3):279-87. PubMed ID: 11564593
    [Abstract] [Full Text] [Related]

  • 4. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy.
    Stone SF, Price P, Brochier J, French MA.
    J Infect Dis; 2001 Oct 15; 184(8):1073-7. PubMed ID: 11574925
    [Abstract] [Full Text] [Related]

  • 5. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease.
    Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French MA, Price P.
    AIDS; 2011 Jul 31; 25(12):1455-60. PubMed ID: 21610488
    [Abstract] [Full Text] [Related]

  • 6. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M, Süsal C, Daniel V, Naujokat C, Zimmermann R, Huth-Kühne A, Opelz G.
    AIDS Res Hum Retroviruses; 2007 Jul 31; 23(7):886-90. PubMed ID: 17678471
    [Abstract] [Full Text] [Related]

  • 7. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P.
    HIV Med; 2008 May 31; 9(5):307-16. PubMed ID: 18400078
    [Abstract] [Full Text] [Related]

  • 8. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease.
    Seddiki N, Sasson SC, Santner-Nanan B, Munier M, van Bockel D, Ip S, Marriott D, Pett S, Nanan R, Cooper DA, Zaunders JJ, Kelleher AD.
    Eur J Immunol; 2009 Feb 31; 39(2):391-403. PubMed ID: 19180462
    [Abstract] [Full Text] [Related]

  • 9. Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.
    Lee S, Almeida CA, French MA, Price P.
    Clin Exp Immunol; 2004 Oct 31; 138(1):110-5. PubMed ID: 15373912
    [Abstract] [Full Text] [Related]

  • 10. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.
    Keane NM, Price P, Stone SF, John M, Murray RJ, French MA.
    AIDS Res Hum Retroviruses; 2000 Dec 10; 16(18):1991-6. PubMed ID: 11153082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Stone SF, French MA.
    Clin Exp Immunol; 2001 Oct 10; 126(1):111-6. PubMed ID: 11678906
    [Abstract] [Full Text] [Related]

  • 13. The Role of IL-27 and its Receptor in the Pathogenesis of HIV/AIDS and Anti-viral Immune Response.
    Zheng YH, Xiao SL, He B, He Y, Zhou HY, Chen Z, Zheng LW, He M, Wang HY, Lin YH, Cao J.
    Curr HIV Res; 2017 Oct 10; 15(4):279-284. PubMed ID: 28521720
    [Abstract] [Full Text] [Related]

  • 14. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y, Luo Y, He Y, Zheng Y, Zhang Q, Zhou H, Zeng S, Chen Z, He B, He M.
    AIDS Res Hum Retroviruses; 2013 Apr 10; 29(4):691-7. PubMed ID: 23151174
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP.
    Clin Infect Dis; 2016 Mar 15; 62(6):795-803. PubMed ID: 26611774
    [Abstract] [Full Text] [Related]

  • 17. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
    Goette NP, Lev PR, Heller PG, Glembotsky AC, Chazarreta CD, Salim JP, Molinas FC, Marta RF.
    Exp Hematol; 2010 Oct 15; 38(10):868-876.e1. PubMed ID: 20600579
    [Abstract] [Full Text] [Related]

  • 18. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY, Guo FP, Han Y, Qiu ZF, Zuo LY, Li YL, Li TS.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2497-502. PubMed ID: 20079166
    [Abstract] [Full Text] [Related]

  • 19. Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapy.
    Ensoli F, Fiorelli V, De Cristofaro M, Collacchi B, Santini Muratori D, Alario C, Sacco G, Iebba F, Aiuti F.
    HIV Med; 2002 Apr 20; 3(2):105-17. PubMed ID: 12010357
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.